Print Page
U.S. Court of Appeals For The Federal Circuit
May 29, 2019 | By S&H
Posted in: S&H IP Blog | U.S. Court of Appeals For The Federal Circuit
Posted in: S&H IP Blog | U.S. Court of Appeals For The Federal Circuit
Cleveland Clinic Foundation v. True Health Diagnostics LLC
On April 1, 2019, the U.S. Court of Appeals for the Federal Circuit (“Federal Circuit”) issue a non-precedential decision in Cleveland Clinic Foundation v. True Health Diagnostics LLC, holding that Cleveland Clinic Foundation”™s (“Cleveland Clinic”) U.S. Patent.
May 29, 2019 | By S&H
Posted in: S&H IP Blog | U.S. Court of Appeals For The Federal Circuit
Posted in: S&H IP Blog | U.S. Court of Appeals For The Federal Circuit
Continental Circuits LLC v. Intel Corporation
On February 8, 2019, the U.S. Court of Appeals for the Federal Circuit (“Federal Circuit”) decided Continental Circuits LLC v. Intel Corporation.
May 29, 2019 | By S&H
Posted in: S&H IP Blog | U.S. Court of Appeals For The Federal Circuit
Posted in: S&H IP Blog | U.S. Court of Appeals For The Federal Circuit
In Re: Guild Mortgage Co.
On January 14, 2019, the U.S. Court of Appeals for the Federal Circuit (“Federal Circuit”) decided In Re: Guild Mortgage Co., holding the U.S. Patent and Trademark Office”™s (“USPTO”) Trademark Trial and Appeal Board (“TTAB”) must consider an applicant”™s evidence and arguments related to absence of actual confusion.
December 13, 2018 | By S&H
Posted in: S&H IP Blog | U.S. Court of Appeals For The Federal Circuit
Posted in: S&H IP Blog | U.S. Court of Appeals For The Federal Circuit
BSG Tech LLC v. BuySeasons, Inc.
On August 15, 2018, the U.S. Court of Appeals for the Federal Circuit (“Federal Circuit”) issued a decision in BSG Tech LLC v. BuySeasons, Inc., holding that when an unconventional feature of the patent claim is determined to be an abstract idea, that unconventional feature cannot make the patent claim eligible under 35 U.S.C §101 (“§ 101”).
December 13, 2018 | By S&H
Posted in: S&H IP Blog | U.S. Court of Appeals For The Federal Circuit
Posted in: S&H IP Blog | U.S. Court of Appeals For The Federal Circuit
Endo Pharm. Solutions Inc. v. Custopharm Inc.
On July 13, 2018, the U.S. Court of Appeals for the Federal Circuit (“Federal Circuit”) held that a prior art reference does not inherently disclose the elements of a claim limitation if the prior art describes the performance of the elements but does not include a complete description of the elements, finding the patents of Endo Pharmaceuticals Solutions Inc. (“Endo”) not invalid for obviousness.